Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study

Background Cumulative exposure to lead is associated with cardiovascular outcomes. Polymorphisms in the δ-aminolevulinic acid dehydratase (ALAD), hemochromatosis (HFE), heme oxygenase-1 (HMOX1), vitamin D receptor (VDR), glutathione S-transferase (GST) supergene family (GSTP1, GSTT1, GSTM1), apolipoprotein E (APOE),angiotensin II receptor-1 (AGTR1) and angiotensinogen (AGT) genes, are believed to alter toxicokinetics and/or toxicodynamics of lead. Objectives We assessed possible effect modification by genetic polymorphisms in ALAD, HFE, HMOX1, VDR, GSTP1, GSTT1, GSTM1, APOE, AGTR1 and AGT individually and as the genetic risk score (GRS) on the association between cumulative lead exposure and incident coronary heart disease (CHD) events. Methods We used K-shell-X-ray fluorescence to measure bone lead levels. GRS was calculated on the basis of 22 lead-related loci. We constructed Cox proportional hazard models to compute adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CHD. We applied inverse probability weighting to account for potential selection bias due to recruitment into the bone lead sub-study. Results Significant effect modification was found by VDR, HMOX1, GSTP1, APOE, and AGT genetic polymorphisms when evaluated individually. Further, the bone lead-CHD associations became larger as GRS increases. After adjusting for potential confounders, a HR of CHD was 2.27 (95%CI: 1.50–3.42) with 2-fold increase in patella lead levels, among participants in the top tertile of GRS. We also detected an increasing trend in HRs across tertiles of GRS (p-trend = 0.0063). Conclusions Our findings suggest that lead-related loci as a whole may play an important role in susceptibility to lead-related CHD risk. These findings need to be validated in a separate cohort containing bone lead, lead-related genetic loci and incident CHD data.

[1]  J. Links,et al.  Associations of Bone Mineral Density and Lead Levels in Blood, Tibia, and Patella in Urban-Dwelling Women , 2008, Environmental health perspectives.

[2]  P. Vokonas,et al.  Longitudinal Changes in Bone Lead Levels: The VA Normative Aging Study , 2011, Journal of occupational and environmental medicine.

[3]  Li Jin,et al.  Haplotype-based case-control study of the human AGTR1 gene and essential hypertension in Han Chinese subjects. , 2010, Clinical biochemistry.

[4]  J. Wetmur.  Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden. , 1994, Environmental health perspectives.

[5]  S. Canizales-Quinteros,et al.  Analysis of polymorphisms and haplotypes in genes associated with vascular tone, hypertension and oxidative stress in Mexican-Mestizo women with severe preeclampsia. , 2013, Clinical biochemistry.

[6]  S. Chanprasertyothin,et al.  Association between Inflammatory Marker, Environmental Lead Exposure, and Glutathione S-Transferase Gene , 2013, BioMed research international.

[7]  C. Fullmer,et al.  Vitamin D and intestinal calcium transport: facts, speculations and hypotheses. , 1995, The Journal of nutrition.

[8]  S. Skerfving,et al.  Modification by the genes ALAD and VDR of lead-induced cognitive effects in children. , 2012, Neurotoxicology.

[9]  Guilin Qiao,et al.  Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  David Simon,et al.  ApoE genotype, past adult lead exposure, and neurobehavioral function. , 2002, Environmental health perspectives.

[11]  R. Desnick,et al.  Lead Binding to δ-Aminolevulinic Acid Dehydratase (ALAD) in Human Erythrocytes , 1997 .

[12]  Ellen K Silbergeld,et al.  Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. , 2006, Circulation.

[13]  S. Shibahara,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. , 2000, American journal of human genetics.

[14]  A. Syvänen,et al.  Identification of a Functional Apolipoprotein E Promoter Polymorphism Regulating Plasma Apolipoprotein E Concentration , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[15]  P. Vokonas,et al.  Iron Metabolism Genes, Low-Level Lead Exposure, and QT Interval , 2008, Environmental health perspectives.

[16]  Kestutis G. Bendinskas,et al.  Effects of lead and mercury on the blood proteome of children. , 2010, Journal of proteome research.

[17]  N. Aykin-Burns,et al.  Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. , 2001, Current topics in medicinal chemistry.

[18]  G. Cooper,et al.  Are vitamin D receptor polymorphisms associated with bone mineral density? A meta‐analysis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  N. Ercal,et al.  N-acetylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress , 1996 .

[20]  Min A. Jhun,et al.  Effect modification by vitamin D receptor genetic polymorphisms in the association between cumulative lead exposure and pulse pressure: a longitudinal study , 2015, Environmental Health.

[21]  Gunnar F. Nordberg,et al.  Handbook on the Toxicology of Metals , 1979 .

[22]  J. Hayes,et al.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.

[23]  T. Lehtimäki,et al.  Association of apolipoprotein E promoter polymorphisms with bone structural traits is modified by dietary saturated fat intake - the Cardiovascular Risk in Young Finns study. , 2011, Bone.

[24]  G. Fénelon,et al.  Prevalence of Apolipoprotein E Phenotypes in Ischemic Cerebrovascular Disease: A Case‐Control Study , 1993, Stroke.

[25]  J. Tanus-Santos,et al.  Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects , 2007, Archives of Toxicology.

[26]  A. Rotnitzky,et al.  Bone lead measured by X-ray fluorescence: epidemiologic methods. , 1995, Environmental health perspectives.

[27]  Zhirong Du,et al.  The Relationship Between Angiotensinogen Gene Polymorphisms and Essential Hypertension in a Northern Han Chinese Population , 2014, Angiology.

[28]  Isabella Annesi-Maesano,et al.  Estimating the health effects of exposure to multi-pollutant mixture. , 2012, Annals of epidemiology.

[29]  A. Jyothy,et al.  Association of GSTM1 & HMOX-1 Gene Polymorphisms in COPD: A study from South Indian Population , 2014 .

[30]  V. Cameron,et al.  Angiotensinogen M235T and T174M Gene Polymorphisms in Combination Doubles the Risk of Mortality in Heart Failure , 2007, Hypertension.

[31]  J. Pounds.  Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. , 1984, Neurotoxicology.

[32]  N. Vaziri,et al.  Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. , 2000, Hypertension.

[33]  S. Hurwitz,et al.  Homeostatic control of plasma calcium concentration. , 1996, Critical reviews in biochemistry and molecular biology.

[34]  W. Stewart,et al.  Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. , 1995, American journal of epidemiology.

[35]  M. Toprak,et al.  Handbook on the Toxicology of Metals , 2014 .

[36]  R. Hornung,et al.  Vitamin D receptor Fok1 polymorphism and blood lead concentration in children. , 2003, Environmental health perspectives.

[37]  R. D. Rudic,et al.  Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.

[38]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[39]  Hak-J Kim,et al.  A polymorphism in AGT and AGTR1 gene is associated with lead-related high blood pressure , 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[40]  D. M. Penny,et al.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Park,et al.  Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre‐ and postmenopausal women , 2009, Clinical endocrinology.

[42]  R. Desnick,et al.  Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. , 1997, Pharmacology & toxicology.

[43]  A. Calafat,et al.  The U.S. National Health and Nutrition Examination Survey and human exposure to environmental chemicals. , 2012, International journal of hygiene and environmental health.

[44]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Weiss,et al.  The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. , 2001, Environmental health perspectives.

[46]  Howard Hu,et al.  Biased Exposure–Health Effect Estimates from Selection in Cohort Studies: Are Environmental Studies at Particular Risk? , 2015, Environmental health perspectives.

[47]  B. Alexander,et al.  Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. , 1998, Environmental health perspectives.

[48]  S. Cole,et al.  Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies , 2009, Epidemiology.

[49]  Bhramar Mukherjee,et al.  HFE H63D Polymorphism as a Modifier of the Effect of Cumulative Lead Exposure on Pulse Pressure: The Normative Aging Study , 2010, Environmental health perspectives.

[50]  N. Ballatori.  Glutathione mercaptides as transport forms of metals. , 1994, Advances in pharmacology.

[51]  G. Davey.  Podoconiosis (nonfilarial elephantiasis) , 2010 .

[52]  R. Abboud,et al.  Effect of heme oxygenase-1 polymorphisms on lung function and gene expression , 2011, BMC Medical Genetics.

[53]  C. Colton,et al.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.

[54]  E. Silverman,et al.  Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study. , 2004, Environmental health perspectives.

[55]  M. Muramatsu,et al.  Association between a Polymorphism of Aminolevulinate Dehydrogenase (ALAD) Gene and Blood Lead Levels in Japanese Subjects , 2009, International journal of environmental research and public health.

[56]  A. Todd,et al.  Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. , 1994, Physics in medicine and biology.

[57]  David J. Weatherall,et al.  Oxford textbook of medicine , 1996 .

[58]  N. Vaziri,et al.  Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-kappaB activation, and overexpression of tubulointerstitial angiotensin II. , 2005, Antioxidants & redox signaling.

[59]  N. Ercal,et al.  N-actylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress. , 1996, Toxicology.

[60]  Y. Rolland,et al.  Bone mineral density in men with genetic hemochromatosis and HFE gene mutation , 2005, Osteoporosis International.

[61]  B. Jaar,et al.  Lead-related nephrotoxicity: a review of the epidemiologic evidence. , 2006, Kidney international.

[62]  C. Ibarra,et al.  Rational modulation of the catalytic activity of A1-1 glutathione S-transferase: evidence for incorporation of an on-face (pi...HO-Ar) hydrogen bond at tyrosine-9. , 1996, Biochemistry.

[63]  Ellen K. Silbergeld,et al.  Blood Lead Below 0.48 &mgr;mol/L (10 &mgr;g/dL) and Mortality Among US Adults , 2006 .

[64]  B. Larijani,et al.  Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension. , 2004, Toxicology letters.

[65]  Gerald Rimbach,et al.  Impact of apoE genotype on oxidative stress, inflammation and disease risk. , 2008, Molecular nutrition & food research.

[66]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[67]  P. Meredith,et al.  Lead exposure and changes in the renin-angiotensin-aldosterone system in man. , 1985, Toxicology letters.